首页> 外文期刊>Oftal mokhirurgiya >D???D?D±DμD?D?D?????D? D′D?D°????D°D3D?D°D???D?D?D1 ????D?Do??D?D? ??D°D′??D?DoD? D???D? ??DμD???D???DμDo??D?D′D?D?D? D?D°D·Dμ??D?D?D? ??D?D???D?D2D?D?D′DμD?D?D? ??D°DoD???D???D?????D???D?DoD°??D?D? D?D° ??D?D?Dμ D???D?D?DμD?DμD?D??? ??D°D·D?D???D????? D?Dμ????Dμ??D?D?D′D????? D???D???D?D2D?D2D???D?D°D?D???DμD???D????? ????DμD′????D2
【24h】

D???D?D±DμD?D?D?????D? D′D?D°????D°D3D?D°D???D?D?D1 ????D?Do??D?D? ??D°D′??D?DoD? D???D? ??DμD???D???DμDo??D?D′D?D?D? D?D°D·Dμ??D?D?D? ??D?D???D?D2D?D?D′DμD?D?D? ??D°DoD???D???D?????D???D?DoD°??D?D? D?D° ??D?D?Dμ D???D?D?DμD?DμD?D??? ??D°D·D?D???D????? D?Dμ????Dμ??D?D?D′D????? D???D???D?D2D?D2D???D?D°D?D???DμD???D????? ????DμD′????D2

机译:D≥D±DμD≥D≥D D'D?D°?????? D°D3D?D°D ??? D?D?D1 ???? D? D?D'?? D?DoD? D? DμD??? D ???DμDo?? D?D'D?D?D? D?D°D·Dμ?? D?D?D? D?D ??? D?D2D?D?D'DμD?D?D? D?DoD ??? D ??? D ??? D ??? D?DoD°?? D?D? D?D°D?D?DμD ??? D?D?DμD?DμD?D ??? D°D·D?D ??? D ?????? D?Dμ??????Dμ?? D?D?D'D ?????? D ??? D ??? D?D2D?D2D ??? D?D°D?D ???DμD??? D ????? DμD′D2

获取原文
       

摘要

Purpose. To compare the efficacy of two different nonsteroidal anti- the conventional phacoemulsification (CPE) was performed using the inflammatory drugs for maintenance of intraoperative mydriasis and to same preoperative instillations. Pupil diameter was registered at 5 surgical define causative factors for laser-induced miosis. steps before FLACS (first pupil diameter a?? I a?? ), before phacoemulsification?? Material and methods. The prospective single center investigation (II a?? ), after viscoinjection (III a?? ), at D?/I of the lens cortex (IV a?? ), at the end included the groups I and II (35 and 30 eyes) where femtosecond laser- of the surgery (V a?? ). Pupil diameter was calculated in the Image J program assisted cataract surgery was carried out with bromfenac 0.09% and version 2.0. Correlation analysis was performed by uniting the groups I indomethacin 0.1% instillations. In the groups III and IV (28 and 34 eyes) and II between intraoperative parameters and pupil diameter. Results. The second degree clinical significant miosis (CSM 2) (postcapsulotomy margin of the capsule was under the iris) was detected in one patient of the group I. In the group II a?? 5 patients had CSM 2 on the different steps of FLACS, the smallest diameter was 4.0 mm (one case a?? IV a?? and one a??V a?? ). There were correlations between II a?? with IOP measured after 15 minutes (r=-0.42, p&0.05), III a?? with IOP that was measured right after femtosecond laser procedure and 15 minutes later (r=-0.38, p&0.05; r=0.35, p&0.05 consecutively). V a?? correlated with IOP measured right after femtosecond laser step and IOP after 15 minutes (r=-0.45, p&0.001; r=0.43, p&0.001, respectively). Low negative correlations of intraoperative miosis were observed with age of the patients. Conclusion. The maintenance of intraoperative mydriasis was more stable in case of bromfenac 0.09% preoperative instillations than using indomethacin 0.1%. The patients who were older and had small pupils prior to the surgery showed a higher reduction of the pupil size. The risk factors for the intraoperative miosis were IOP spikes that occurred in the time period of 15 minutes after femtosecond laser procedure.
机译:目的。为了比较两种不同的非甾体抗炎药的功效,使用炎症药物进行了常规的超声乳化术(CPE),以维持术中瞳孔散大和术前滴注相同。在5个手术定义的激光诱发瞳孔缩小的致病因素中记录了瞳孔直径。超声乳化前在FLACS之前的步骤(第一瞳孔直径a ?? I a ??)。材料与方法。粘膜注射(IIIaβ)后,在晶状体皮层的D 1 / I(IVaβ)进行的前瞻性单中心研究(IIaβ),最后包括I组和II组(35和30组)眼睛)手术的飞秒激光(V a ??)。在Image J程序辅助的白内障手术中使用0.09%的溴芬酸和2.0版计算瞳孔直径。通过组合第I组吲哚美辛0.1%滴注进行相关分析。在第三和第四组(28和34眼)和第二组中,术中参数和瞳孔直径之间。结果。在第一组中的一名患者中检测到了二级临床显着瞳孔缩小(CSM 2)(囊切开术后切缘在虹膜下)。 5例在FLACS的不同步骤上具有CSM 2的患者,最小直径为4.0 mm(1例a ?? IV a?和1 a ?? V a ??)。 II a ??之间存在相关性? 15分钟后测得的IOP(r = -0.42,p <0.05),IIIa?在飞秒激光手术后立即和15分钟后测量IOP(r = -0.38,p <0.05; r = 0.35,p <0.05)。 V a ??与飞秒激光步进之后立即测量的IOP和15分钟后测量的IOP相关(r = -0.45,p <0.001; r = 0.43,p <0.001)。术中瞳孔缩小与患者年龄的负相关性较低。结论。术前滴注0.09%的溴芬酸比使用吲哚美辛0.1%的术中散瞳的维持更为稳定。年龄较大且术前瞳孔较小的患者表现出瞳孔大小的减小。术中瞳孔缩小的危险因素是飞秒激光手术后15分钟内发生的IOP尖峰。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号